Literature DB >> 17647056

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Ryoko Sasaki1,2, Yuichiro Takeda3,4, Osamu Funato3, Hiroyuki Nitta3, Hidenobu Kawamura3, Noriyuki Uesugi4, Tamotsu Sugai4, Go Wakabayashi3, Nobuhiro Ohkohchi5.   

Abstract

OBJECTIVES: The objective of this study was to determine whether carcinoma in situ at the bile duct margin is prognostically different from residual invasive carcinoma in patients with extrahepatic cholangiocarcinoma. Although there are many reports that the ductal margin status at bile duct resection stumps is a prognostic indicator in patients with extrahepatic cholangiocarcinoma, some patients who undergo resection with microscopic tumor involvement of the bile duct margin survive longer than expected.
METHODS: A retrospective clinicopathological analysis of 128 patients who had undergone surgical resection for extrahepatic cholangiocarcinoma was conducted. The status of the bile duct resection margin was classified as negative in 105 patients (82.0%), positive for carcinoma in situ in 12 patients (9.4%), and positive for invasive carcinoma in 11 patients (8.6%).
RESULTS: Ductal margin status was an independent prognostic indicator by both univariate (p = 0.0022) and multivariate (p = 0.0105) analyses, along with lymph node metastasis. There was no significant difference between patients with a negative ductal margin and those with a positive ductal margin with carcinoma in situ (p = 0.5247). The 5-year survival rate of patients with a positive ductal margin with carcinoma in situ (22.2%) was significantly better (p = 0.0241) than with invasive carcinoma (0%). There was a significant relationship between local recurrence and ductal margin status (p = 0.0401).
CONCLUSIONS: Among patients undergoing surgical resection for extrahepatic cholangiocarcinoma, invasive carcinoma at the ductal resection margins appears to have a significant relation to local recurrence and also a significant negative impact on survival, whereas residual carcinoma in situ does not. Discrimination whether carcinoma in situ or invasive carcinoma is present is important in clinical setting in which the resection margin at the ductal stump is positive.

Entities:  

Mesh:

Year:  2007        PMID: 17647056     DOI: 10.1007/s00268-007-9102-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Outcome of treatment for distal bile duct cancer.

Authors:  Y Fong; L H Blumgart; E Lin; J G Fortner; M F Brennan
Journal:  Br J Surg       Date:  1996-12       Impact factor: 6.939

2.  Surgical pathology of cholangiocarcinoma of the liver hilus (Klatskin tumor).

Authors:  A Bosma
Journal:  Semin Liver Dis       Date:  1990-05       Impact factor: 6.115

3.  Surgical management of hilar cholangiocarcinoma.

Authors:  Alan W Hemming; Alan I Reed; Shiro Fujita; David P Foley; Richard J Howard
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

Review 4.  Hilar cholangiocarcinoma: a review and commentary.

Authors:  R S Chamberlain; L H Blumgart
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

Review 5.  What constitutes long-term survival after surgery for hilar cholangiocarcinoma?

Authors:  J Klempnauer; G J Ridder; M Werner; A Weimann; R Pichlmayr
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

6.  Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.

Authors:  Jin-Young Jang; Sun-Whe Kim; Do Joong Park; Young Joon Ahn; Yoo-Seok Yoon; Min Gew Choi; Kyung-Suk Suh; Kuhn Uk Lee; Yong-Hyun Park
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

7.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

Review 8.  Surgical management of cholangiocarcinoma.

Authors:  William R Jarnagin; Margo Shoup
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

9.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

10.  Outcomes after curative resections of cholangiocarcinoma.

Authors:  D M Nagorney; J H Donohue; M B Farnell; C D Schleck; D M Ilstrup
Journal:  Arch Surg       Date:  1993-08
View more
  43 in total

Review 1.  [Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors].

Authors:  J Munding; A Tannapfel
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Relationship between the surgical margin status, prognosis, and recurrence in extrahepatic bile duct cancer patients.

Authors:  Hiroshi Kurahara; Kosei Maemura; Yuko Mataki; Masahiko Sakoda; Satoshi Iino; Yota Kawasaki; Shinichiro Mori; Yuko Kijima; Shinichi Ueno; Hiroyuki Shinchi; Sonshin Takao; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2016-08-05       Impact factor: 3.445

3.  Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.

Authors:  Haixia Yang; Jiupeng Zhou; Xin Wei; Fan Wang; Huadong Zhao; Enxiao Li
Journal:  Mol Clin Oncol       Date:  2014-08-07

Review 4.  Surgical resection techniques for locally advanced hilar cholangiocarcinoma.

Authors:  Sanjay Govil; Mettu Srinivas Reddy; Mohamed Rela
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

5.  Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations.

Authors:  Kiichi Tamada; Jun Ushio; Kentaro Sugano
Journal:  World J Clin Oncol       Date:  2011-05-10

6.  A case of distal extrahepatic cholangiocarcinoma with two positive resection margins.

Authors:  Wayne A Warner; Wesley Ramcharan; Dave Harnanan; Srikanth Umakanthan; Ravi Maharaj
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

7.  The puzzle and challenge in the treatment of an intraoperative margin-positive proximal bile duct in hilar cholangiocarcinoma.

Authors:  Fei Liu; Wen-Jie Ma; Hai-Jie Hu; Parbatraj Regmi; Jun-Ke Wang; Fu-Yu Li
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

8.  Duct-to-duct biliary reconstruction after radical resection of Bismuth IIIa hilar cholangiocarcinoma.

Authors:  Wen-Guang Wu; Jun Gu; Ping Dong; Jian-Hua Lu; Mao-Lan Li; Xiang-Song Wu; Jia-Hua Yang; Lin Zhang; Qi-Chen Ding; Hao Weng; Qian Ding; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

9.  Value of multidetector row CT in the assessment of longitudinal extension of cholangiocarcinoma: correlation between MDCT and microscopic findings.

Authors:  Yoshiki Senda; Hideki Nishio; Koji Oda; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Teiichi Sugiura; Yoshie Shimoyama; Yuji Nimura; Masato Nagino
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

Review 10.  Hepatopancreatoduodenectomy for anastomotic recurrence from residual cholangiocarcinoma: report of a case.

Authors:  Seiji Natsume; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Masato Nagino
Journal:  Surg Today       Date:  2013-05-24       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.